Author Archives: Casey Fullem

About Casey Fullem

Casey Fullem, Marketing Coordinator at Golden Helix, joined team in October of 2021. He is an analytics driven digital marketer that values tactile marketing efforts that yield return. Building a cohesive brand and executing performative marketing campaigns is his passion, alongside the slew of outdoor activities that Bozeman has to offer. Casey is largely passionate about skiing, rock climbing, whitewater kayaking and rafting, fly fishing, backpacking, and other outdoor activities that excite.

Join Golden Helix at PacBio PRISM 2024

         April 25, 2024

Golden Helix is gearing up for PacBio PRISM 2024, where they will showcase their genomic solutions in multiple U.S. cities. The events will occur in Bethesda, Houston, San Francisco, and Boston throughout May. These events offer a prime opportunity to network with fellow researchers, gain valuable insights, and find inspiration for your lab work. Don’t miss out on the chance… Read more »

Advancing Genetic Research: The Role of VarSeq and VS-CNV in Breakthrough Discoveries

         March 31, 2024

In the rapidly evolving field of genomics, innovative technologies, and methodologies are constantly being developed to enhance our understanding and diagnosis of genetic disorders. Golden Helix’s VarSeq and VS-CNV software platforms stand at the forefront of this revolution, offering powerful tools for genetic data analysis and interpretation. This blog highlights recent research endeavors where these tools have been instrumental. From… Read more »

Golden Helix VarSeq in Action – P715: Analyzing performance of the Twist exome with CNV backbone at various probe densities leveraging Golden Helix VS-CNV

         March 22, 2024

Recently, at ACMG 2024, we unveiled a collaborative research project with Twist Biosciences. By utilizing Twist Bioscience enhanced Exome 2.0 Plus Comprehensive Exome Spike-In capture panel with added backbone probes, we developed a multi-modal CNV caller designed specifically for target-capture NGS data to detect single-exon to whole-chromosome aneuploid CNV events. We are proud to say that from Golden Helix, Andreas… Read more »

CIO Bulletin – Innovation Excellence Awards

         March 12, 2024

Leading the Genomic Revolution with VarSeq Suite, Revolutionizing Precision Medicine, and Envisioning a Path for Healthier Tomorrow: Golden Helix Inc We recently were awarded by CIO Bulletin 2024, a winner of their Innovation Excellence Awards. Due to our groundbreaking contributions to the field of precision medicine, this recognition is greatly appreciated. Here’s a summary of the key highlights: In conclusion,… Read more »

Golden Helix is Launching VSPGx

         February 27, 2024

VSPGx is a pharmacogenomics interpretation software based on CPIC recommendations. The field of pharmacogenetics bridges genetics and pharmacology, with the aim of optimizing drug therapies for individual patients based on their unique genetic makeup. It has the potential to revolutionize healthcare by improving drug efficacy, reducing adverse reactions, and advancing the concept of personalized medicine moving away from a one… Read more »

We Are Heading to Toronto!

         February 27, 2024

Join Golden Helix at the American College of Medical Genetics and Genomics (ACMG) 2024 conference and discover the latest advances in genetic research. This premier event brings together leading researchers, clinicians, and industry experts to share their insights on cutting-edge topics in medical genetics. Stop by our booth for a live demo of our software, learn about the latest features,… Read more »

Exploring the Genetic Frontier: Advances in Understanding Eye Disorders

         January 30, 2024

Welcome to the exploration of groundbreaking genetic research in ophthalmology. Recent studies have unveiled fascinating insights into the complex interplay between genetics and eye diseases, offering hope and new directions for understanding and treating these conditions. From novel genetic variants linked to microphthalmia and glaucoma to the long-term implications of cataract surgery in childhood, we’re diving into the depths of… Read more »

VarSeq in Action: Deciphering Complex Genetic Puzzles in Immune Thrombocytopenia, Glaucoma, and Rare Syndromes

         December 31, 2023

In this blog, we explore the impactful applications of VarSeq in genetic research and diagnostics. Through case studies, we examine its role in diverse conditions like Immune Mediated Thrombocytopenia (ITP), glaucoma, and Cri du Chat syndrome. These studies demonstrate VarSeq’s capability in identifying genetic variants and influencing diagnosis and treatment across various medical scenarios, showcasing its crucial role in advancing… Read more »

Golden Helix 2024 Innovation Awards

         December 7, 2023

In the ever-evolving world of clinical research, Golden Helix consistently stands at the forefront, empowering researchers with cutting-edge software tools. This year, the Golden Helix 2024 Innovation Awards take center stage, offering a unique platform for innovators and researchers to showcase their groundbreaking work. Running from December 1, 2023, to February 29, 2024, these awards are a celebration of ingenuity… Read more »

Decoding Complex Genetics: VarSeq’s Pivotal Role in Melanoma and Autism Spectrum Disorder Research

         November 30, 2023

In the rapidly evolving field of genetic research, VarSeq software by Golden Helix stands out as a powerful tool for genetic analysis and interpretation. This is exemplified in two significant customer publications that demonstrate the versatility and impact of VarSeq in advancing our understanding of complex genetic disorders. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients Increased genetic… Read more »

Introducing VarSeq 2.5.0: Elevating NGS Labs to New Heights

         November 9, 2023

We’re buzzing with excitement and couldn’t wait to share some groundbreaking news with our community: VarSeq 2.5.0 has officially landed, and it’s here to transform your NGS lab experience! What’s New with VarSeq 2.5.0? VarSeq has always been about innovation and pushing the boundaries, and the 2.5.0 update is no exception. We’ve listened to your feedback and supercharged VarSeq with… Read more »

Join Us at AMP 2023 for a Deep Dive into Genomic Data Analysis with VarSeq

         November 9, 2023

We are excited to announce that Golden Helix will be participating in AMP 2023, a pivotal event that brings together experts and innovators in the field of molecular pathology. This year, we are proud to present a session that is at the forefront of precision medicine: “Comprehensive Genomic Profiling in Oncology: Apply the AMP Guidelines for TSO-500 Variant Analysis and… Read more »

Deciphering the Genetic Code of Disease: Insights from VarSeq-Analyzed Research on Human and Feline Conditions

         October 31, 2023

In the ever-evolving field of genetics, the quest to understand the intricate dance between genetic predispositions and disease manifestations continues to gain momentum. The three research papers presented here offer a glimpse into this complex interplay, each exploring the genetic underpinnings of distinct medical conditions across species. From the debilitating effects of acute retinal necrosis in humans to the life-threatening… Read more »

Emerging Insights in Medical Research: Explorations with VarSeq

         September 28, 2023

Recent advancements in medical research have been pivotal in deepening our understanding of a variety of health conditions. The utilization of tools such as VarSeq in these studies allows for comprehensive genomic analyses, thereby ensuring more accurate diagnoses and facilitating the development of targeted treatments. This bloghighlights three recent publications that have utilized VarSeq to unravel the mysteries of different… Read more »

Decoding DNA: Unraveling the Genetic Mysteries of Cancer Susceptibility

         August 31, 2023

In an era where genetics is reshaping our understanding of diseases, recent customer research publications offer invaluable insights, particularly in the realm of cancer. A study titled “Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients” dives into a rare phenotype bridging hereditary colorectal and breast cancer syndromes, revealing the profound impact of… Read more »

Advancing Precision Medicine: A Spotlight on Golden Helix’s VarSeq in Genomic Research and Clinical Applications

         August 1, 2023

The field of genomics and precision medicine is rapidly evolving, bringing forth innovative diagnostic and treatment approaches. The cutting-edge techniques and technologies discussed in the following papers provide insight into how whole-exome sequencing (WES), whole-genome sequencing (WGS), and deep computational analysis are reshaping healthcare. Our spotlight is on recent customer publications featuring the study of a unique heritable form of… Read more »

2023 Innovation Award Winner: Dr. Muthukumaran

         July 6, 2023

We would like to extend our heartfelt thanks to everyone who participated in our 2023 Innovation Awards Competition. Each year, we are profoundly inspired by the innovative applications and groundbreaking research conducted using Golden Helix software globally. With immense excitement, we are thrilled to announce this year’s winner! Dr. Muthukumaran is a Team Lead and Clinical Bioinformatician at Anderson Diagnostics… Read more »

Unlocking Genetic Mysteries: Celebrating Customer Innovations with VarSeq Software

         June 27, 2023

At Golden Helix, our community of customers and researchers is at the core of our commitment to advancing genomic research and precision medicine. We are thrilled to highlight some recent customer publications that have made innovative use of our VarSeq software in their research. These studies, which span across diverse fields including cardiology and oncology, illustrate the versatile applications of… Read more »

We are Headed to AMP Europe 2023!

         June 12, 2023

Discover the Latest Developments in Variant Classification and Interpretation Tools at Golden Helix’s Booth at AMP Europe 2023 in Milan, Italy We are thrilled to announce that Golden Helix will be participating in the AMP Europe 2023 conference in Milan! We are eagerly looking forward to connecting with leading healthcare professionals and researchers in the field of genetics at this… Read more »

We are Headed to ESHG 2023!

         June 6, 2023

Explore the Newest Developments in Variant Classification and Interpretation Tools at Golden Helix’s Booth at ESHG 2023 We are excited to announce that Golden Helix will be attending the ESHG 2023 conference in Glasgow! We can’t wait to connect with leading healthcare professionals and researchers in the field of genetics at this premier event. Find us in Booth #566 Be sure… Read more »